News

The project aims at mechanistic modeling of antibodies to predict pharmacokinetics and target occupancy in cerebrospinal fluid

InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with discoveric bio alpha, a biotechnology company taking next generation antibody technologies into Alzheimer’s Disease

The path of a Quantitative Systems Pharmacology company to optimize drug development

This year InSysBio celebrates its 20-year anniversary. Now InSysBio specializes in Quantitative Systems Pharmacology (QSP) modeling services and QSP software infrastructure development and operates in the global market.

Now B cells model reflects the current views on the processes

InSysBio launches Immune Response Template (IRT) version 3.6.3. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system

InSysBio held its 14th Annual Internal Scientific Meeting on February 11-13, 2024. The Meeting was organized for the first time after the pandemic and InSysBio’s Headquarters relocation to Cyprus.

InSysBio’s Heta language is now supported by Sublime Text

InSysBio launches the new Plugin for Sublime Text editor to highlight Heta language code. Heta project is InSysBio’s initiative for the development of infrastructure for modeling in pharmacology and systems biology.

fIVE Calculator is Shiny application to estimate model parameters

Now InSysBio presents public beta release of fIVE Calculator which is a web application designed to automatically calculate kinetic parameters from in vitro experiments for modeling of biosystems.